Citation 128160

GALVEZ,J: PEDRO DE LA CRUZ,J: ZARZUELO,A: SANCHEZ DE LA CUESTA,F:. (1995). FLAVONOID INHIBITION OF ENZYMIC AND NONENZYMIC LIPID PEROXIDATION IN RAT LIVER DIFFERS FROM ITS INFLUENCE ON THE GLUTATHIONE-RELATED ENZYMES.. 51(2)

Citation Details

Title	FLAVONOID INHIBITION OF ENZYMIC AND NONENZYMIC LIPID PEROXIDATION IN RAT LIVER DIFFERS FROM ITS INFLUENCE ON THE GLUTATHIONE-RELATED ENZYMES.
Authors	GALVEZ,J: PEDRO DE LA CRUZ,J: ZARZUELO,A: SANCHEZ DE LA CUESTA,F:
Year	1995
Volume	51
Issue	2

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE
2	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE
3	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	INACTIVE
4	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	INACTIVE
5	GLUTATHIONE PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	INACTIVE
6	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
7	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
8	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	ACTIVE
9	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	WEAK ACTIVITY
10	GLUTATHIONE PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUTEOLIN	INACTIVE
11	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
12	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
13	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
14	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	WEAK ACTIVITY
15	GLUTATHIONE PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
16	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
17	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
18	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
19	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
20	GLUTATHIONE PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
21	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DELPHINIDIN	ACTIVE
22	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DELPHINIDIN	ACTIVE
23	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DELPHINIDIN	WEAK ACTIVITY
24	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DELPHINIDIN	WEAK ACTIVITY
25	GLUTATHIONE PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DELPHINIDIN	INACTIVE
26	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
27	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
28	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	WEAK ACTIVITY
29	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
30	GLUTATHIONE PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
31	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
32	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
33	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
34	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
35	GLUTATHIONE PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
36	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
37	LIPID PEROXIDE FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	ACTIVE
38	GLUTATHIONE-S-TRANSFERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	WEAK ACTIVITY
39	GLUTATHIONE REDUCTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE
40	GLUTATHIONE PEROXIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NARINGENIN	INACTIVE

Citation 128160

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1